Elizabeth Nora Fojtik, MD Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 1236 Huffman Mill Rd Ste 1300, Burlington, NC 27215 Phone: 336-584-5544 Fax: 336-584-4436 |
Mr. Gabriel John Illes Iii, DPT, PT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 3701 Wade Coble Dr, Burlington, NC 27215 Phone: 336-538-1500 |
Dr. Benjamin Charles Chasnis, M.D. Physical Medicine & Rehabilitation - Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1234 Huffman Mill Rd, Burlington, NC 27215 Phone: 336-538-1234 Fax: 336-538-2390 |
News Archive
Advaxis, Inc., (OTCQB: ADXS), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that it has been granted Orphan Drug Designation from the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development (OOPD) for ADXS-HPV, its lead drug candidate, for the treatment of human papillomavirus (HPV)-associated anal cancer.
A new study reveals that rising rates of liver cancer deaths in the United States have largely been confined to individuals who have received less education, especially among men.
Medtronic, Inc. today announced that a landmark publication highlighting results from the pivotal study for Medtronic Deep Brain Stimulation (DBS) Therapy for epilepsy, known as SANTEĀ® (Stimulation of the Anterior Nucleus of the Thalamus in Epilepsy), was published online today in the medical journal, Epilepsia. The SANTE study, sponsored by Medtronic, is the largest and most rigorous clinical study of DBS therapy for epilepsy in adults with medically refractory epilepsy with partial-onset seizures.
The prescription drug epidemic continues to take lives in America, causing 100 overdose deaths daily, according to the Centers for Disease Control and Prevention.
› Verified 7 days ago